Genomic Valley Biotech informs about quarterly statement on investor complaints

18 Jul 2016 Evaluate

Genomic Valley Biotech has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

25.98 0.82 (3.26%)
08-Jan-2026 14:42 View Price Chart
Peers
Company Name CMP
Venkys India 1536.05
Mangalam Global Ent 13.98
Kaveri Seed 910.20
Regaal Resources 70.55
Simran Farms 165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×